MYPN

myopalladin, the group of I-set domain containing

Basic information

Region (hg38): 10:68087897-68212017

Links

ENSG00000138347NCBI:84665OMIM:608517HGNC:23246Uniprot:Q86TC9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • dilated cardiomyopathy 1KK (Limited), mode of inheritance: AD
  • familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
  • familial isolated restrictive cardiomyopathy (Supportive), mode of inheritance: AD
  • childhood-onset nemaline myopathy (Supportive), mode of inheritance: AD
  • cap myopathy (Supportive), mode of inheritance: AD
  • dilated cardiomyopathy 1KK (Limited), mode of inheritance: AD
  • MYPN-related myopathy (Strong), mode of inheritance: AR
  • MYPN-related myopathy (Definitive), mode of inheritance: AR
  • hypertrophic cardiomyopathy (Disputed Evidence), mode of inheritance: AD
  • dilated cardiomyopathy (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, dilated, 1KK; Cardiomyopathy, familial hypertrophic, 22; Cardiomyopathy, dilated, 1KKADCardiovascularSurveillance (eg, including echocardiogram and electrocardiogram) and preventive measures related to cardiac manifestations may allow early diagnosis and management, which may reduce morbidity and mortalityCardiovascular; Neurologic18006477; 22286171; 22892539; 28017374

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYPN gene.

  • Dilated cardiomyopathy 1KK (18 variants)
  • Cardiovascular phenotype (7 variants)
  • not provided (2 variants)
  • MYPN-related myopathy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYPN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
331
clinvar
8
clinvar
342
missense
751
clinvar
22
clinvar
5
clinvar
778
nonsense
10
clinvar
3
clinvar
3
clinvar
16
start loss
1
clinvar
1
frameshift
14
clinvar
5
clinvar
6
clinvar
25
inframe indel
6
clinvar
6
splice donor/acceptor (+/-2bp)
10
clinvar
5
clinvar
15
splice region
17
24
1
42
non coding
8
clinvar
130
clinvar
120
clinvar
258
Total 24 18 783 483 133

Highest pathogenic variant AF is 0.0000132

Variants in MYPN

This is a list of pathogenic ClinVar variants found in the MYPN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-68109676-G-A not specified Likely benign (Mar 12, 2018)515937
10-68109732-C-T not specified • MYPN-related myopathy;Dilated cardiomyopathy 1KK Benign (Feb 23, 2022)138420
10-68113992-T-C Likely benign (Nov 15, 2021)1684054
10-68114079-G-A Benign (Nov 15, 2019)1240558
10-68114130-G-C Likely benign (Jun 25, 2020)1193134
10-68114347-C-CT Benign (Feb 03, 2020)1291626
10-68114347-C-CTT Likely benign (Nov 19, 2019)1190956
10-68114451-C-A Likely benign (Nov 15, 2019)1215748
10-68121288-A-T Benign (Jun 19, 2018)1241484
10-68121325-C-T Benign (Jun 19, 2018)1280430
10-68121346-A-T Benign (Jun 18, 2018)1268364
10-68121394-C-T Benign (Jun 14, 2018)1268670
10-68121440-T-C Uncertain significance (Jun 01, 2024)2672397
10-68121451-A-C Dilated cardiomyopathy 1KK Uncertain significance (Dec 24, 2017)544040
10-68121455-T-C Dilated cardiomyopathy 1KK • Cardiovascular phenotype Uncertain significance (Apr 22, 2023)646574
10-68121459-A-C Dilated cardiomyopathy 1KK Uncertain significance (Jan 01, 2023)1470941
10-68121460-G-A Dilated cardiomyopathy 1KK Uncertain significance (Jul 14, 2021)1477999
10-68121460-G-C Dilated cardiomyopathy 1KK Uncertain significance (Nov 08, 2022)1348029
10-68121461-C-T Cardiovascular phenotype Uncertain significance (Dec 23, 2020)1790708
10-68121472-A-G Dilated cardiomyopathy 1KK • Cardiovascular phenotype Uncertain significance (Apr 05, 2021)1446990
10-68121473-T-C Primary familial hypertrophic cardiomyopathy • Dilated cardiomyopathy 1KK • Cardiovascular phenotype Uncertain significance (Jul 27, 2023)222747
10-68121476-C-G Dilated cardiomyopathy 1KK Uncertain significance (Aug 15, 2022)1359484
10-68121477-T-C not specified Likely benign (Jan 25, 2018)515086
10-68121480-G-A Dilated cardiomyopathy 1KK • Cardiovascular phenotype Likely benign (Apr 12, 2024)976553
10-68121485-T-C Dilated cardiomyopathy 1KK • Cardiovascular phenotype Uncertain significance (Mar 09, 2022)544041

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYPNprotein_codingprotein_codingENST00000358913 19105863
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002611.001256960521257480.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1297167260.9860.00004228620
Missense in Polyphen261284.240.918233471
Synonymous-0.8042922751.060.00001702669
Loss of Function4.652159.80.3510.00000347677

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003220.000322
Ashkenazi Jewish0.000.00
East Asian0.0004890.000489
Finnish0.0001390.000139
European (Non-Finnish)0.0002290.000229
Middle Eastern0.0004890.000489
South Asian0.00006530.0000653
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the sarcomere that tethers together nebulin (skeletal muscle) and nebulette (cardiac muscle) to alpha-actinin, at the Z lines. {ECO:0000269|PubMed:11309420}.;
Disease
DISEASE: Cardiomyopathy, dilated 1KK (CMD1KK) [MIM:615248]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:18006477, ECO:0000269|PubMed:22286171, ECO:0000269|PubMed:22892539}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 22 (CMH22) [MIM:615248]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:22286171}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial restrictive 4 (RCM4) [MIM:615248]: A heart disorder characterized by impaired filling of the ventricles with reduced diastolic volume, in the presence of normal or near normal wall thickness and systolic function. {ECO:0000269|PubMed:22286171}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Integrin-mediated Cell Adhesion (Consensus)

Recessive Scores

pRec
0.111

Intolerance Scores

loftool
0.578
rvis_EVS
0.81
rvis_percentile_EVS
87.76

Haploinsufficiency Scores

pHI
0.286
hipred
Y
hipred_score
0.511
ghis
0.475

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.559

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Mypn
Phenotype
muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype;

Gene ontology

Biological process
homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;sarcomere organization;dendrite self-avoidance
Cellular component
nucleus;plasma membrane;Z disc;axon;I band
Molecular function
actin binding;protein binding;cytoskeletal protein binding;SH3 domain binding;muscle alpha-actinin binding;cell-cell adhesion mediator activity